Prof Martin Brutsche
Chefarzt Pneumologie und interdisziplinäres Schlafzentrum
Chefarzt/Chefärztin
Pneumologie und Schlafmedizin · Dept. I
Baseline predictors of adherence to positive airway pressure therapy for sleep apnea: a 10-year single-center observational cohort study
Schoch O, Baty F, Niedermann J, Rüdiger J, Brutsche M. Baseline predictors of adherence to positive airway pressure therapy for sleep apnea: a 10-year single-center observational cohort study. Respiration 2013; 87:121-8.
05.11.2013Baseline predictors of adherence to positive airway pressure therapy for sleep apnea: a 10-year single-center observational cohort study
05.11.2013Respiration 2013; 87:121-8
Schoch Otto, Baty Florent, Niedermann Jolanda, Rüdiger Jochen, Brutsche Martin
Endobronchial ultrasound-guided transbronchial needle aspiration of an intravascular sarcoma metastasis
Dusemund F, Schneider T, Zeisel C, Rothermundt C, Kluckert T, Schmid S, Brutsche M. Endobronchial ultrasound-guided transbronchial needle aspiration of an intravascular sarcoma metastasis. Respiration 2013; 86:430-432.
24.09.2013Endobronchial ultrasound-guided transbronchial needle aspiration of an intravascular sarcoma metastasis
24.09.2013Respiration 2013; 86:430-432
Dusemund Frank, Schneider Tino, Zeisel Christoph, Rothermundt Christian, Kluckert Thomas, Schmid Sabine, Brutsche Martin
EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer
Baty F, Brutsche M, Pless M, Zappa F, Crowe S, Bubendorf L, Gautschi O, Rauch D, Cathomas R, Dröge C, Betticher D, Früh M, Rothschild S, Swiss Group for Clinical Cancer Research. EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer. PloS one 2013; 8:e72966.
10.09.2013EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer
10.09.2013PloS one 2013; 8:e72966
Baty Florent, Brutsche Martin, Pless Miklos, Zappa Francesco, Crowe Susanne, Bubendorf Lukas, Gautschi Oliver, Rauch Daniel, Cathomas Richard, Dröge Cornelia, Betticher Daniel, Früh Martin, Rothschild Sacha, Swiss Group for Clinical Cancer Research
Characteristics of medically and surgically treated empyema patients: a retrospective cohort study
Dusemund F, Weber M, Nagel W, Schneider T, Brutsche M, Schoch O. Characteristics of medically and surgically treated empyema patients: a retrospective cohort study. Respiration 2013; 86:288-94.
27.08.2013Characteristics of medically and surgically treated empyema patients: a retrospective cohort study
27.08.2013Respiration 2013; 86:288-94
Dusemund Frank, Weber M D, Nagel Wolfgang, Schneider Tino, Brutsche Martin, Schoch Otto
Exploring the transcription factor activity in high-throughput gene expression data using RLQ analysis
Baty F, Rüdiger J, Miglino N, Kern L, Borger P, Brutsche M. Exploring the transcription factor activity in high-throughput gene expression data using RLQ analysis. BMC bioinformatics 2013; 14:178.
06.06.2013Exploring the transcription factor activity in high-throughput gene expression data using RLQ analysis
06.06.2013BMC bioinformatics 2013; 14:178
Baty Florent, Rüdiger Jochen, Miglino Nicola, Kern Lukas, Borger Peter, Brutsche Martin
Comorbidities and Burden of COPD: A Population Based Case-Control Study
Baty F, Putora P, Isenring B, Blum T, Brutsche M. Comorbidities and Burden of COPD: A Population Based Case-Control Study. PloS one 2013; 8:e63285.
17.05.2013Comorbidities and Burden of COPD: A Population Based Case-Control Study
17.05.2013PloS one 2013; 8:e63285
Baty Florent, Putora Paul Martin, Isenring Bruno, Blum Torsten, Brutsche Martin
Epidermal Growth Factor Receptor Mutation in a Patient with Squamous Cell Carcinoma of the Lung: Who Should Be Tested?
Schwitter M, Früh M, Schneider T, Kluckert J, Rodriguez R, Brutsche M. Epidermal Growth Factor Receptor Mutation in a Patient with Squamous Cell Carcinoma of the Lung: Who Should Be Tested?. Oncology 2013; 2013:263-268.
14.05.2013Epidermal Growth Factor Receptor Mutation in a Patient with Squamous Cell Carcinoma of the Lung: Who Should Be Tested?
14.05.2013Oncology 2013; 2013:263-268
Schwitter Michael, Früh Martin, Schneider Tino, Kluckert Jörg-Thomas, Rodriguez Regulo, Brutsche Martin
Epidermal growth factor receptor mutation in a patient with squamous cell carcinoma of the lung: who should be tested?
Schwitter M, Rodriguez R, Schneider T, Kluckert T, Brutsche M, Früh M. Epidermal growth factor receptor mutation in a patient with squamous cell carcinoma of the lung: who should be tested?. Case Rep Oncol 2013; 6:263-8.
14.05.2013Epidermal growth factor receptor mutation in a patient with squamous cell carcinoma of the lung: who should be tested?
14.05.2013Case Rep Oncol 2013; 6:263-8
Schwitter Michael, Rodriguez Regulo, Schneider Tino, Kluckert Thomas, Brutsche Martin, Früh Martin
Sarkoidose: ein klinisch orientierter Überblick
Finger R, Rodriguez R, Schönegg R, Kluckert J, Brutsche M. Sarkoidose: ein klinisch orientierter Überblick. Schweizerisches Medizin Forum 2013:265-270.
26.03.2013Sarkoidose: ein klinisch orientierter Überblick
26.03.2013Schweizerisches Medizin Forum 2013:265-270
Finger Rebekka, Rodriguez Regulo, Schönegg René, Kluckert Jörg-Thomas, Brutsche Martin
Analysis of the EGFR Mutation Status in Head and Neck Squamous Cell Carcinoma before Treatment with Gefitinib
Bontognali S, Pless M, Brutsche M, Fischer C, Rochlitz C, Buess M. Analysis of the EGFR Mutation Status in Head and Neck Squamous Cell Carcinoma before Treatment with Gefitinib. Onkologie 2013; 36:161-6.
18.03.2013Analysis of the EGFR Mutation Status in Head and Neck Squamous Cell Carcinoma before Treatment with Gefitinib
18.03.2013Onkologie 2013; 36:161-6
Bontognali Sven, Pless Miklos, Brutsche Martin, Fischer Claude, Rochlitz Christoph, Buess Martin
Diagnosis and management of chronic obstructive pulmonary disease: the swiss guidelines: official guidelines of the Swiss Respiratory Society
Russi E, Steurer-Stey C, Rochat T, Quadri F, Nicod L, Kuhn M, Geiser T, Frey M, Fitting J, Eich C, Brutsche M, Karrer W, Stolz D. Diagnosis and management of chronic obstructive pulmonary disease: the swiss guidelines: official guidelines of the Swiss Respiratory Society. Respiration 2013; 85:160-74.
11.02.2013Diagnosis and management of chronic obstructive pulmonary disease: the swiss guidelines: official guidelines of the Swiss Respiratory Society
11.02.2013Respiration 2013; 85:160-74
Russi E W, Steurer-Stey C, Rochat T, Quadri F, Nicod L, Kuhn M, Geiser T, Frey M, Fitting J W, Eich C, Brutsche Martin, Karrer W, Stolz D
VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528
Gautschi O, Stahel R, Carbone D, Na K, Hsu Schmitz S, Bubendorf L, Baty F, Brutsche M, Pless M, Zappa F, Roder J, Grigorieva J, Roder H, Peters S, Crowe S, Dingemans A, Smit E. VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. Lung Cancer 2012; 79:59-64.
01.11.2012VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528
01.11.2012Lung Cancer 2012; 79:59-64
Gautschi Oliver, Stahel Rolf, Carbone David, Na Kyung-Jae, Hsu Schmitz Shu-Fang, Bubendorf Lukas, Baty Florent, Brutsche Martin, Pless Miklos, Zappa Francesco, Roder Joanna, Grigorieva Julia, Roder Heinrich, Peters Solange, Crowe Susanne, Dingemans Anne-Marie, Smit Egbert
Asthma and the regulated retrotransposon transcriptome
Miglino N, Roth M, Baty F, Brutsche M, Tamm M, Borger P. Asthma and the regulated retrotransposon transcriptome. Eur Respir J. 2012; 40:788-90.
01.09.2012Asthma and the regulated retrotransposon transcriptome
01.09.2012Eur Respir J. 2012; 40:788-90
Miglino Nicola, Roth Michael, Baty Florent, Brutsche Martin, Tamm Michael, Borger Pieter
Interstitial Pneumonitis after Treatment with Pemetrexed: A Rare Event?
Hochstrasser A, Benz G, Jörger M, Templeton A, Brutsche M, Früh M. Interstitial Pneumonitis after Treatment with Pemetrexed: A Rare Event?. Chemotherapy 2012; 58:84-88.
23.02.2012Interstitial Pneumonitis after Treatment with Pemetrexed: A Rare Event?
23.02.2012Chemotherapy 2012; 58:84-88
Hochstrasser Andreas, Benz Gabriel, Jörger Markus, Templeton Arnoud, Brutsche Martin, Früh Martin
Tracheal granuloma pyogenicum with erlotinib treatment for lung cancer
Putora P, Benz G, Rodriguez R, Brutsche M, Früh M. Tracheal granuloma pyogenicum with erlotinib treatment for lung cancer. Eur Respir J. 2011; 38:1228-30.
01.11.2011Tracheal granuloma pyogenicum with erlotinib treatment for lung cancer
01.11.2011Eur Respir J. 2011; 38:1228-30
Putora Paul Martin, Benz Gabriel, Rodriguez Regulo, Brutsche Martin, Früh Martin
Progressive static pulmonary hyperinflation in survivors of severe bronchopulmonary dysplasia by mid-adulthood
Trachsel D, Brutsche M, Hug-Batschelet H, Hammer J. Progressive static pulmonary hyperinflation in survivors of severe bronchopulmonary dysplasia by mid-adulthood. Thorax 2011
25.08.2011Progressive static pulmonary hyperinflation in survivors of severe bronchopulmonary dysplasia by mid-adulthood
25.08.2011Thorax 2011
Trachsel Daniel, Brutsche Martin, Hug-Batschelet Henriette, Hammer Jürg
Long-term treatment with infliximab in patients with sarcoidosis
Hostettler K, Studler U, Tamm M, Brutsche M. Long-term treatment with infliximab in patients with sarcoidosis. Respiration 2011; 83:218-24.
29.07.2011Long-term treatment with infliximab in patients with sarcoidosis
29.07.2011Respiration 2011; 83:218-24
Hostettler Katrin E, Studler Ueli, Tamm Michael, Brutsche Martin
Management of parapneumonic effusion and empyema: medical thoracoscopy and surgical approach
Robert J, Brutsche M. Management of parapneumonic effusion and empyema: medical thoracoscopy and surgical approach. Respiration 2011; 82:193-6.
07.04.2011Management of parapneumonic effusion and empyema: medical thoracoscopy and surgical approach
07.04.2011Respiration 2011; 82:193-6
Robert John, Brutsche Martin
Advances in Personalized Cancer Management
Früh M, Baty F, Putora P, Brutsche M. Advances in Personalized Cancer Management. In: Advances in Personalized Cancer Management. NovemberLondon: Future Medicine Ltd, 2010. ISBN 978-1-78084-068-0. S. 58-67.
01.01.2011Advances in Personalized Cancer Management
01.01.2011Future Medicine Ltd, ISBN 978-1-78084-068-0
Früh Martin, Baty Florent, Putora Paul Martin, Brutsche Martin
Behandlung des Pleuraempyems mittels internistischer Thorakoskopie
Brutsche M. Behandlung des Pleuraempyems mittels internistischer Thorakoskopie. Der Pneumologe 2010; 7:349-356.
01.09.2010Behandlung des Pleuraempyems mittels internistischer Thorakoskopie
01.09.2010Der Pneumologe 2010; 7:349-356
Brutsche Martin